$TKMR Recent Headlines Newscast: Stocks finis
Post# of 144798
Posted On: 08/18/2014 1:11:53 PM
$TKMR Recent Headlines
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
Monster Beverage jumps; Zynga sinks on results 4:37 p.m. Aug. 8, 2014 - Sue Chang
Dow gain biggest in over 4 months 4:09 p.m. Aug. 8, 2014 - Anora Mahmudova
Ebola drug maker's shares soar as FDA opens door to treatment use 12:20 p.m. Aug. 8, 2014 - Russ Britt
Tekmira moves closer to approval on Ebola drug 10:27 a.m. Aug. 8, 2014 - Russ Britt
Jobs pop, Dan Loeb's wisdom, Apple's iPad woes 9:01 a.m. May 2, 2014 - Shawn Langlois
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Tekmira Pharmaceuticals up 10% in premarket 9:00 a.m. July 18, 2012 - Steve Gelsi
UPDATE: Leerink Says Tekmira Is 'Uniquely Positioned' 10:10 a.m. Today - benzinga.com
Benzinga's Top Initiations 8:10 a.m. Today - benzinga.com
Tekmira Pharmaceuticals (TKMR): Today's Pre-Market Leader Stock 8:05 a.m. Today - TheStreet.com
Tekmira set for gap up at the open 7:56 a.m. Today - Seeking Alpha
Tekmira Up 6% On Leerink Initiation 7:41 a.m. Today - benzinga.com
Leerink Partners Initiates Tekmira Pharmaceuticals At Outperform 7:00 a.m. Today - benzinga.com
10-Q: TEKMIRA PHARMACEUTICALS CORP 5:13 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Today's Market: Biotech And Technology Names Moving On News 1:33 p.m. Aug. 14, 2014 - Seeking Alpha
Ebola vaccine trials are a top priority for medical authorities 1:20 p.m. Aug. 14, 2014 - Seeking Alpha
'Fast Money' Recap: Some Good, Some Bad for Cisco 5:00 a.m. Aug. 14, 2014 - TheStreet.com
Tekmira Pharmaceuticals' (TKMR) CEO Mark Murray on Q2 2014 Results - Earnings Call Transcript 6:35 p.m. Aug. 13, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock: Tekmira Pharmaceuticals (TKMR) 10:26 a.m. Aug. 13, 2014 - TheStreet.com
Tekmira Shares Continue to Rise in the Search for Ebola Cure - Analyst Blog 4:20 p.m. Aug. 12, 2014 - Zacks.com
2 Stocks Only Day Traders Can Love 10:31 a.m. Aug. 12, 2014 - Seeking Alpha
Stock To Watch: Tekmira Pharmaceuticals (TKMR) In Perilous Reversal 9:45 a.m. Aug. 12, 2014 - TheStreet.com
Tekmira Pharma Soars on FDA Announcement over Ebola Drug - Analyst Blog 4:30 p.m. Aug. 11, 2014 - Zacks.com
Jim Cramer Answers Twitter (TWTR) Questions on Tesla (TSLA), Tekmira (TKMR), Alcoa (AA) and SolarCity (SCTY) 12:13 p.m. Aug. 11, 2014 - TheStreet.com
Heavy Early Morning Activity On Tekmira Pharmaceuticals (TKMR) 9:07 a.m. Aug. 11, 2014 - TheStreet.com
Cramer's Lightning Round - Everyone Is Panicking About Rite Aid (8/8/14) 6:24 a.m. Aug. 11, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Not Selling Rite-Aid 6:00 a.m. Aug. 9, 2014 - TheStreet.com
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium 10:25 a.m. April 1, 2014 - GlobeNewswire
Tekmira Announces Completion of Underwritten Public Offering of Common Stock 1:54 p.m. March 18, 2014 - GlobeNewswire
Tekmira Announces Pricing of Underwritten Public Offering of Common Stock 9:02 a.m. March 13, 2014 - GlobeNewswire
Tekmira Announces Proposed Public Offering of Common Stock 4:40 p.m. March 10, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces Year-End 2013 Results 8:30 a.m. March 6, 2014 - GlobeNewswire
Tekmira Receives Fast Track Designation From FDA for Its Anti-Ebola Viral Therapeutic 5:07 p.m. March 5, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and 2013 Year-End Financial Results 5:07 p.m. March 4, 2014 - GlobeNewswire
Tekmira Presents Recent Advances in mRNA Delivery at Scientific Symposium 5:48 a.m. Feb. 25, 2014 - GlobeNewswire
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
Monster Beverage jumps; Zynga sinks on results 4:37 p.m. Aug. 8, 2014 - Sue Chang
Dow gain biggest in over 4 months 4:09 p.m. Aug. 8, 2014 - Anora Mahmudova
Ebola drug maker's shares soar as FDA opens door to treatment use 12:20 p.m. Aug. 8, 2014 - Russ Britt
Tekmira moves closer to approval on Ebola drug 10:27 a.m. Aug. 8, 2014 - Russ Britt
Jobs pop, Dan Loeb's wisdom, Apple's iPad woes 9:01 a.m. May 2, 2014 - Shawn Langlois
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Tekmira Pharmaceuticals up 10% in premarket 9:00 a.m. July 18, 2012 - Steve Gelsi
UPDATE: Leerink Says Tekmira Is 'Uniquely Positioned' 10:10 a.m. Today - benzinga.com
Benzinga's Top Initiations 8:10 a.m. Today - benzinga.com
Tekmira Pharmaceuticals (TKMR): Today's Pre-Market Leader Stock 8:05 a.m. Today - TheStreet.com
Tekmira set for gap up at the open 7:56 a.m. Today - Seeking Alpha
Tekmira Up 6% On Leerink Initiation 7:41 a.m. Today - benzinga.com
Leerink Partners Initiates Tekmira Pharmaceuticals At Outperform 7:00 a.m. Today - benzinga.com
10-Q: TEKMIRA PHARMACEUTICALS CORP 5:13 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Today's Market: Biotech And Technology Names Moving On News 1:33 p.m. Aug. 14, 2014 - Seeking Alpha
Ebola vaccine trials are a top priority for medical authorities 1:20 p.m. Aug. 14, 2014 - Seeking Alpha
'Fast Money' Recap: Some Good, Some Bad for Cisco 5:00 a.m. Aug. 14, 2014 - TheStreet.com
Tekmira Pharmaceuticals' (TKMR) CEO Mark Murray on Q2 2014 Results - Earnings Call Transcript 6:35 p.m. Aug. 13, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock: Tekmira Pharmaceuticals (TKMR) 10:26 a.m. Aug. 13, 2014 - TheStreet.com
Tekmira Shares Continue to Rise in the Search for Ebola Cure - Analyst Blog 4:20 p.m. Aug. 12, 2014 - Zacks.com
2 Stocks Only Day Traders Can Love 10:31 a.m. Aug. 12, 2014 - Seeking Alpha
Stock To Watch: Tekmira Pharmaceuticals (TKMR) In Perilous Reversal 9:45 a.m. Aug. 12, 2014 - TheStreet.com
Tekmira Pharma Soars on FDA Announcement over Ebola Drug - Analyst Blog 4:30 p.m. Aug. 11, 2014 - Zacks.com
Jim Cramer Answers Twitter (TWTR) Questions on Tesla (TSLA), Tekmira (TKMR), Alcoa (AA) and SolarCity (SCTY) 12:13 p.m. Aug. 11, 2014 - TheStreet.com
Heavy Early Morning Activity On Tekmira Pharmaceuticals (TKMR) 9:07 a.m. Aug. 11, 2014 - TheStreet.com
Cramer's Lightning Round - Everyone Is Panicking About Rite Aid (8/8/14) 6:24 a.m. Aug. 11, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Not Selling Rite-Aid 6:00 a.m. Aug. 9, 2014 - TheStreet.com
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium 10:25 a.m. April 1, 2014 - GlobeNewswire
Tekmira Announces Completion of Underwritten Public Offering of Common Stock 1:54 p.m. March 18, 2014 - GlobeNewswire
Tekmira Announces Pricing of Underwritten Public Offering of Common Stock 9:02 a.m. March 13, 2014 - GlobeNewswire
Tekmira Announces Proposed Public Offering of Common Stock 4:40 p.m. March 10, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces Year-End 2013 Results 8:30 a.m. March 6, 2014 - GlobeNewswire
Tekmira Receives Fast Track Designation From FDA for Its Anti-Ebola Viral Therapeutic 5:07 p.m. March 5, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and 2013 Year-End Financial Results 5:07 p.m. March 4, 2014 - GlobeNewswire
Tekmira Presents Recent Advances in mRNA Delivery at Scientific Symposium 5:48 a.m. Feb. 25, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼